A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation

Delphi G. M. Coppens; Sofieke de Wilde; Henk J. Guchelaar; Marie L. De Bruin; Hubert G. M. Leufkens; Pauline Meij; Jarno Hoekman

A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation

Delphi G. M. Coppens, Sofieke de Wilde, Henk J. Guchelaar, Marie L. De Bruin, Hubert G. M. Leufkens, Pauline Meij, Jarno Hoekman

Original language	English
Publication date	Aug 2018
Publication status	Published - Aug 2018

Cite this

@conference{b9a55e48130640cfa26799bd2dfd7fe6,

title = "A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation",

author = "Coppens, {Delphi G. M.} and {de Wilde}, Sofieke and Guchelaar, {Henk J.} and {De Bruin}, {Marie L.} and Leufkens, {Hubert G. M.} and Pauline Meij and Jarno Hoekman",

year = "2018",

month = aug,

language = "English",

pages = "517--517",

}

TY - ABST

T1 - A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation

AU - Coppens, Delphi G. M.

AU - de Wilde, Sofieke

AU - Guchelaar, Henk J.

AU - De Bruin, Marie L.

AU - Leufkens, Hubert G. M.

AU - Meij, Pauline

AU - Hoekman, Jarno

PY - 2018/8

Y1 - 2018/8

M3 - Conference abstract for conference

SP - 517

EP - 517

ER -